Oramed Pharmaceuticals Inc.
ORMP
Revenue
2.00M
▲1.33M▲196.74%
21 Months ChangeAssets
220.49M
▲58.81M▲36.37%
3 Months ChangeLiabilities
17.21M
▲10.06M▲140.55%
3 Months ChangeFree Cash Flow
-3.52M
▼-2.04M▼-138.29%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-20
Form 8-K
ID: 0001012975-26-000195
2026-01-14
Form 8-K
ID: 0001213900-26-004382
2026-01-07
Form 8-K
ID: 0001213900-26-001983
2025-12-31
Form 8-K
ID: 0001213900-25-127133
2025-12-31
Form 8-K
ID: 0001012975-25-000992
2025-11-17
Form 8-K
ID: 0001213900-25-111310
2025-11-17
Form 8-K
ID: 0001213900-25-111298
2025-11-13
Form 10-Q
ID: 0001213900-25-109980
2025-10-24
Form 8-K
ID: 0001213900-25-101825
2025-10-06
Form 8-K
ID: 0001213900-25-096322